Hepatotoxicity induced by zoledronic acid in an aged woman with primary osteoporosis

Zoledronic acid, a bisphosphonate, has been approved for treatment and prevention of osteoporosis. This case describes a 73-year-old woman with primary osteoporosis who developed transient hepatotoxicity after zoledronic acid (ZOL) treatment. Three days after ZOL infusion, aspartate aminotransferase...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yanhui, Pei, Yu, Shao, Yinghong, Yan, Shuangtong, Ma, Lichao, Fang, Fusheng, Jin, Mengmeng, Liu, Minyan, Li, Jian, Li, Chunlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Leibniz Research Centre for Working Environment and Human Factors 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803018/
https://www.ncbi.nlm.nih.gov/pubmed/27034632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803018/
https://www.ncbi.nlm.nih.gov/pubmed/27034632

Ejemplares similares